Search by Drug Name or NDC
NDC 54738-0025-03 Meclizine HCL 25 mg/1 Details
Meclizine HCL 25 mg/1
Meclizine HCL is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Richmond Pharmaceuticals, Inc.. The primary component is MECLIZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
Related Packages: 54738-0025-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Meclizine
Product Information
NDC | 54738-0025 |
---|---|
Product ID | 54738-025_5cc4c45d-5b77-0912-e053-2991aa0a10a5 |
Associated GPIs | 50200050000510 |
GCN Sequence Number | 004736 |
GCN Sequence Number Description | meclizine HCl TAB CHEW 25 MG ORAL |
HIC3 | H6J |
HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
GCN | 18312 |
HICL Sequence Number | 001975 |
HICL Sequence Number Description | MECLIZINE HCL |
Brand/Generic | Generic |
Proprietary Name | Meclizine HCL |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Meclizine HCl 25mg Chewable Tablets |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 25 |
Active Ingredient Units | mg/1 |
Substance Name | MECLIZINE HYDROCHLORIDE |
Labeler Name | Richmond Pharmaceuticals, Inc. |
Pharmaceutical Class | Antiemetic [EPC], Emesis Suppression [PE] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part336 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 54738-0025-03 (54738002503)
NDC Package Code | 54738-025-03 |
---|---|
Billing NDC | 54738002503 |
Package | 1000 TABLET, CHEWABLE in 1 BOTTLE (54738-025-03) |
Marketing Start Date | 2015-05-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 98e3fe5a-73c6-4dcc-b397-cc6013beee43 Details
Uses
Warnings
Ask a doctor before use if you have
- glaucoma
- a breathing problem such as emphysema or chronic bronchitis
- trouble urinating due to an elarged prostate gland
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
When using this product
- you may get drowsy
- avoid alcoholic drinks
- alcohol, sedatives and tranquilizers may increse drowsiness
- be careful when driving a moor vehicle or operating machinery
Directions
Keep out of reach of children.
OTHER INFORMATION
Questions or Comments
Inactive ingredients
Package/Label Principal Display Panel
INGREDIENTS AND APPEARANCE
MECLIZINE HCL
meclizine hcl 25mg chewable tablets tablet, chewable |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Richmond Pharmaceuticals, Inc. (043569607) |
Registrant - Advance Pharmaceutical Inc. (078301063) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Advance Pharmaceutical Inc. | 078301063 | manufacture(54738-025) |
Revised: 10/2017
Document Id: 5cc4c45d-5b77-0912-e053-2991aa0a10a5
Set id: 98e3fe5a-73c6-4dcc-b397-cc6013beee43
Version: 3
Effective Time: 20171030